Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson B Rodrigues

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Applied Neuropsychology. Adult|June 24, 2024
The classification accuracy of Warrington's recognition memory test (words) as a performance validity Test in a neurorehabilitation settingJenna Parsons, Nelson B Rodrigues, Laszlo A Erdodi
Brain Sciences|February 1, 2018
The Emerging Role of Tractography in Deep Brain Stimulation: Basic Principles and Current ApplicationsNelson B Rodrigues, Karim Mithani, Ying Meng, et al.
Journal of Psychopharmacology (Oxford, England)|March 13, 2024
Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depressionNelson B Rodrigues, David Chen-Li, Joshua D Di Vincenzo, et al.
Psychiatry Research|September 3, 2024
Pentoxifylline for bipolar depression: A pilot studyNelson B Rodrigues, Simina Toma, Roger S McIntyre, et al.
Journal of Psychiatric Research|November 29, 2021
Pharmacogenomics of ketamine: A systematic reviewShakila Meshkat, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
CNS Spectrums|December 3, 2020
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of ExcellenceOrly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Journal of Affective Disorders|December 24, 2021
The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depressionSabine El-Halabi, Daniel H Cooper, Danielle S Cha, et al.
Neuroscience and Biobehavioral Reviews|November 26, 2020
The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future ResearchHartej Gill, Barjot Gill, Nelson B Rodrigues, et al.
Psychiatry Research|October 4, 2022
Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysisShakila Meshkat, Yazen Alnefeesi, Muhammad Youshay Jawad, et al.
Journal of Psychiatric Research|September 10, 2021
Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of ExcellenceJoshua D Di Vincenzo, Orly Lipsitz, Nelson B Rodrigues, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Applied Neuropsychology. Adult|June 24, 2024
The classification accuracy of Warrington's recognition memory test (words) as a performance validity Test in a neurorehabilitation settingJenna Parsons, Nelson B Rodrigues, Laszlo A Erdodi
Brain Sciences|February 1, 2018
The Emerging Role of Tractography in Deep Brain Stimulation: Basic Principles and Current ApplicationsNelson B Rodrigues, Karim Mithani, Ying Meng, et al.
Journal of Psychopharmacology (Oxford, England)|March 13, 2024
Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depressionNelson B Rodrigues, David Chen-Li, Joshua D Di Vincenzo, et al.
Psychiatry Research|September 3, 2024
Pentoxifylline for bipolar depression: A pilot studyNelson B Rodrigues, Simina Toma, Roger S McIntyre, et al.
Journal of Psychiatric Research|November 29, 2021
Pharmacogenomics of ketamine: A systematic reviewShakila Meshkat, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
CNS Spectrums|December 3, 2020
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of ExcellenceOrly Lipsitz, Roger S McIntyre, Nelson B Rodrigues, et al.
Journal of Affective Disorders|December 24, 2021
The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depressionSabine El-Halabi, Daniel H Cooper, Danielle S Cha, et al.
Neuroscience and Biobehavioral Reviews|November 26, 2020
The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future ResearchHartej Gill, Barjot Gill, Nelson B Rodrigues, et al.
Psychiatry Research|October 4, 2022
Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysisShakila Meshkat, Yazen Alnefeesi, Muhammad Youshay Jawad, et al.
Journal of Psychiatric Research|September 10, 2021
Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of ExcellenceJoshua D Di Vincenzo, Orly Lipsitz, Nelson B Rodrigues, et al.
Pageof 7